Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Bulut, Nilufer ^a   Aksoy, Sercan ^a   Dizdar, Omer ^a   Dede, Didem S ^a   Arslan, Cagatay ^a   Dogan, Erkan ^a   Gullu, Ibrahim ^a   Ozisik, Yavuz ^a   Altundag, Kadri ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Non triple negative; Prognosis; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER;

EID: 84655170207     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9715-9     Document Type: Article

References (16)

1. JS Reis-Filho AN Tutt 2008 Triple negative tumours: a critical review Histopathology 52 108 118 (Pubitemid 350265179)
2. C Arslan O Dizdar K Altundag 2009 Pharmacotherapy of triple-negative breast cancer Expert Opin Pharmacother 10 2081 2093
3. WJ Irvin Jr LA Carey 2008 What is triple-negative breast cancer? Eur J Cancer 44 2799 2805
4. LA Carey CM Perou CA Livasy 2006 Race, breast cancer subtypes, and survival in the Carolina breast cancer study Jama 295 2492 2502 (Pubitemid 43854964)
5. G Stockmans K Deraedt H Wildiers P Moerman R Paridaens 2008 Triple-negative breast cancer Curr Opin Oncol 20 614 620
6. M Tischkowitz JS Brunet LR Begin 2007 Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 134
7. R Dent WM Hanna M Trudeau 2009 Pattern of metastatic spread in triple-negative breast cancer Breast Cancer Res Treat 115 423 428
8. R Dent M Trudeau KI Pritchard 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429 4434 (Pubitemid 47219710)
9. F Kassam K Enright R Dent 2009 Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design Clin Breast Cancer 9 29 33
10. XR Yang ME Sherman DL Rimm 2007 Differences in risk factors for breast cancer molecular subtypes in a population-based study Cancer Epidemiol Biomarkers Prev 16 439 443 (Pubitemid 46548646)
11. CA Livasy G Karaca R Nanda 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 264 271 (Pubitemid 43117611)
12. B Van Calster I Vanden Bempt M Drijkoningen 2009 Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive Breast Cancer Res Treat 113 181 187
13. WJ Yin JS Lu GH Di 2009 Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Res Treat 115 325 333
14. Burnell MJ, O'Connor EM, Chapman JW, et al. Triple-negative receptor status and prognosis in the NCIC CTG MA.21 adjuvant breast cancer trial. (abstract 550)mn. J Clin Oncol. 2008;26.
15. SM Rodriguez-Pinilla D Sarrio E Honrado 2006 Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas Clin Cancer Res 12 1533 1539
16. C Lin SY Chien LS Chen 2009 Triple negative breast carcinoma is a prognostic factor in Taiwanese women BMC Cancer 9 192